Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications (Q40339607)
scientific article published on December 2005
Language:
(P31) (Q13442814)
(P50) (Q87712102)
(Q28421846)
(Q89228014)
(Q117224711)
(Q114455520)
(Q92660028)
(Q114300414)
(Q39949167)
(Q67500242)
(Q117224725)
(Q96098386)
(Q117224784)
(Q100761370)
(P304) 11712-11720
(P407) (Q1860)
(P433) 24
(P478) 65
(P577) Thursday, December 1, 2005
(P921) (Q246181)
(Q467635)
(P1433) (Q326097)
(P1476) "Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications" (language: en)
(P2093) Yu-Tzu Tai
Xian-Feng Li
Rory Coffey
(P2860) (Q40566183)
other details
description scientific article published on December 2005

External Links